LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,482,000 | +40.3% | 29,400 | -8.5% | 0.00% | +50.0% |
| Q4 2020 | $3,195,000 | +2.4% | 32,123 | -1.8% | 0.00% | -33.3% |
| Q3 2020 | $3,119,000 | -12.7% | 32,723 | +2.5% | 0.00% | -25.0% |
| Q2 2020 | $3,571,000 | +28.8% | 31,923 | -16.3% | 0.00% | +33.3% |
| Q1 2020 | $2,773,000 | -73.6% | 38,138 | -62.2% | 0.00% | -70.0% |
| Q4 2019 | $10,516,000 | +167.2% | 100,839 | +155.1% | 0.01% | +150.0% |
| Q3 2019 | $3,935,000 | +20.5% | 39,532 | +38.2% | 0.00% | 0.0% |
| Q2 2019 | $3,266,000 | -13.6% | 28,610 | -4.8% | 0.00% | -20.0% |
| Q1 2019 | $3,778,000 | -29.8% | 30,051 | -24.2% | 0.01% | -37.5% |
| Q4 2018 | $5,382,000 | -52.2% | 39,658 | -3.4% | 0.01% | -46.7% |
| Q3 2018 | $11,271,000 | +36.1% | 41,063 | +2.7% | 0.02% | +36.4% |
| Q2 2018 | $8,282,000 | +15.9% | 39,977 | -7.6% | 0.01% | +10.0% |
| Q1 2018 | $7,148,000 | +24.3% | 43,278 | +3.1% | 0.01% | +25.0% |
| Q4 2017 | $5,750,000 | +1.9% | 41,995 | +1.3% | 0.01% | 0.0% |
| Q3 2017 | $5,643,000 | +18.0% | 41,449 | +5.2% | 0.01% | 0.0% |
| Q2 2017 | $4,783,000 | +19.9% | 39,400 | +4.5% | 0.01% | +14.3% |
| Q1 2017 | $3,990,000 | +3.6% | 37,700 | -0.5% | 0.01% | +16.7% |
| Q4 2016 | $3,851,000 | -14.3% | 37,900 | -13.9% | 0.01% | -14.3% |
| Q3 2016 | $4,491,000 | -27.9% | 44,000 | -15.7% | 0.01% | -30.0% |
| Q2 2016 | $6,226,000 | +14.7% | 52,200 | +3.0% | 0.01% | +11.1% |
| Q1 2016 | $5,429,000 | -18.3% | 50,700 | -17.3% | 0.01% | -18.2% |
| Q4 2015 | $6,646,000 | +34.5% | 61,300 | +6.2% | 0.01% | +37.5% |
| Q3 2015 | $4,942,000 | -8.8% | 57,700 | +7.4% | 0.01% | 0.0% |
| Q2 2015 | $5,418,000 | +97.7% | 53,700 | +14.7% | 0.01% | +100.0% |
| Q1 2015 | $2,741,000 | 0.0% | 46,800 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,741,000 | +6.5% | 46,800 | -14.6% | 0.00% | 0.0% |
| Q3 2014 | $2,574,000 | -24.6% | 54,777 | 0.0% | 0.00% | -20.0% |
| Q2 2014 | $3,412,000 | +8.1% | 54,777 | +14.8% | 0.01% | 0.0% |
| Q1 2014 | $3,157,000 | +21.5% | 47,700 | 0.0% | 0.01% | +25.0% |
| Q4 2013 | $2,598,000 | +7322.9% | 47,700 | +5832.8% | 0.00% | – |
| Q3 2013 | $35,000 | -91.5% | 804 | -92.7% | 0.00% | -100.0% |
| Q2 2013 | $412,000 | – | 11,004 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |